CAS 610798-31-7: Icotinib
Fórmula:C22H21N3O4
InChI:InChI=1S/C22H21N3O4/c1-2-16-4-3-5-17(12-16)25-22-18-13-20-21(14-19(18)23-15-24-22)29-11-9-27-7-6-26-8-10-28-20/h1,3-5,12-15H,6-11H2,(H,23,24,25)
Clave InChI:InChIKey=QQLKULDARVNMAL-UHFFFAOYSA-N
SMILES:C#CC1=CC=CC(=C1)NC=2N=CN=C3C=C4OCCOCCOCCOC4=CC32
- Sinónimos:
- Bpi 2009H
- Icotinib int. N-1
- N-(3-Ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine
- [1,4,7,10]Tetraoxacyclododecino[2,3-g]quinazolin-4-amine, N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-
- Icotinib
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
![]() | Icotinib REF: TM-T6153CAS: 610798-31-7 | 100% | 48,00 €~712,00 € | Mar 08 Abr 25 |
![]() | 4-(3-Ethynylphenyl)amino)-6,7-benzo-12-crown-4-quinazoline REF: 3D-FE146411CAS: 610798-31-7 | Min. 95% | - - - | Producto descatalogado |
![discount label](https://static.cymitquimica.com/public/img/discount.png)
Icotinib
CAS:610798-31-7
Icotinib (Conmana) is an orally available quinazoline-based inhibitor of epidermal growth factor receptor (EGFR), with …
Fórmula:
C22H21N3O4
Pureza:
100%
Forma y color:
Solid
Peso molecular:
391.42
Ref: TM-T6153
1mg | 48,00 € | ||
2mg | 64,00 € | ||
5mg | 96,00 € | ||
10mg | 155,00 € | ||
25mg | 283,00 € | ||
50mg | 527,00 € | ||
100mg | 712,00 € | ||
1mL*10mM (DMSO) | 97,00 € |
Entrega estimada en Estados Unidos, el Martes 8 de Abril de 2025
![discount label](https://static.cymitquimica.com/public/img/discount.png)
4-(3-Ethynylphenyl)amino)-6,7-benzo-12-crown-4-quinazoline
CAS:610798-31-7
4-(3-Ethynylphenyl)amino)-6,7-benzo-12-crown-4-quinazoline is a topoisomerase inhibitor that has been shown to inhibit the proliferation of cancer …
Pureza:
Min. 95%
Ref: 3D-FE146411
5mg | Descatalogado | Solicitar información | |
10mg | Descatalogado | Solicitar información | |
25mg | Descatalogado | Solicitar información | |
50mg | Descatalogado | Solicitar información | |
100mg | Descatalogado | Solicitar información |